Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare USTEKINUMAB (YESINTEK) and USTEKINUMAB-AEKN (Ustekinumab-aekn) — clinical data, side effects, and patient experiences.
YESINTEK, Stelara · Biologic (IL-12/23 Inhibitor)
How it works
12.1 Mechanism of Action Ustekinumab products are human IgG1қ monoclonal antibodies that binds with specificity to the p40 protein subunit used by both the IL-12 and IL-23 cytokine...
Approved for
Ustekinumab-aekn · Biologic (IL-12/23 Inhibitor)
How it works
12.1 Mechanism of Action Ustekinumab products are human IgG1κ monoclonal antibodies that bind with specificity to the p40 protein subunit used by both the IL-12 and IL-23 cytokines...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 15 Reddit discussions
USTEKINUMAB
33%
positive
15 threads
USTEKINUMAB-AEKN
0%
positive
0 threads
% of discussions mentioning each side effect
15 Reddit threads analysed for USTEKINUMAB
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
18 upvotes
Most discussed side effects in community
Even though several of these medications are manufactured in the USA, it doesn't mean it's cheaper in the USA. "Socialised healthcare" negotiates in a free market outside the USA. No wonder travel insurance costs a fortune in USA. Detailed story..... https://www.msn.com/en-au/health/other/doctors-
Welcome back to this week's newsflash 1. Surgery for UC can be a major life change, but it is often a necessary step when medications fail. Understanding the adjustments to diet and daily life afterward is crucial for recovery and long-term well-being. This guide explores what patients can expect re
#The Effectiveness of Medications for Ulcerative Colitis *This post was last revised September 19, 2019.* Here I have compiled data on the effectiveness of medications used to treat ulcerative colitis, as compared to placebos or to other medications. ###Risk Ratios (RRs) All values here are shown as
Since eternacept started to wear off over the years my docs gave me the choice to switch to Ustekinumab. The 3 months injection rhythm sounds pretty unreal when coming from 3-day-interval Eternacept jabs, but well.. you could call it progress in medical science. I am now 3 weeks in after my first do
I wanted to follow-up on a previous post I made regarding starting Stelara. https://old.reddit.com/r/Psoriasis/comments/yjhr6z/plaque_psoriasis_after_a_covid_vaccine/ I have now be on Stelara for 7 months and it has nearly cleared my Psoriasis. I stopped applying Clobetasol some months ago and each
I’ve been on biologics for about a year now, i started in December 2024. About 45ml shot of Ustekinumab every 3 months as prescribed by my dermatologist. Problem is, it is losing its efficacy. Since August, every time it clears up about 70%, the same thing happens, it comes back worse even with topi
Phase 3 trials to commence. Possibly another biological option. http://www.medscape.com/viewarticle/878838
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
No community discussions found for USTEKINUMAB-AEKN yet.
Both USTEKINUMAB and USTEKINUMAB-AEKN belong to the Biologic (IL-12/23 Inhibitor) class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. USTEKINUMAB is administered via Subcutaneous or Intravenous, whereas USTEKINUMAB-AEKN uses Subcutaneous. Route of administration can affect onset of action and patient adherence.
Both medications are approved for See full prescribing information. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
USTEKINUMAB carries 4 FDA warnings. USTEKINUMAB-AEKN carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.